- Home
- VELO vs ANIX Comparison
VELO vs ANIX Comparison
Compare VELO & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VELO
- ANIX
- Stock Information
- Founded
- VELO 2014
- ANIX 1982
- Country
- VELO United States
- ANIX United States
- Employees
- VELO N/A
- ANIX N/A
- Industry
- VELO Industrial Machinery/Components
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- VELO Technology
- ANIX Health Care
- Exchange
- VELO Nasdaq
- ANIX Nasdaq
- Market Cap
- VELO 85.8M
- ANIX 95.7M
- IPO Year
- VELO N/A
- ANIX 1987
- Fundamental
- Price
- VELO $3.60
- ANIX $2.97
- Analyst Decision
- VELO
- ANIX Strong Buy
- Analyst Count
- VELO 0
- ANIX 3
- Target Price
- VELO N/A
- ANIX $9.00
- AVG Volume (30 Days)
- VELO 1.4M
- ANIX 65.7K
- Earning Date
- VELO 11-07-2025
- ANIX 08-27-2025
- Dividend Yield
- VELO N/A
- ANIX N/A
- EPS Growth
- VELO N/A
- ANIX N/A
- EPS
- VELO N/A
- ANIX N/A
- Revenue
- VELO $43,765,000.00
- ANIX N/A
- Revenue This Year
- VELO N/A
- ANIX N/A
- Revenue Next Year
- VELO N/A
- ANIX N/A
- P/E Ratio
- VELO N/A
- ANIX N/A
- Revenue Growth
- VELO N/A
- ANIX N/A
- 52 Week Low
- VELO $1.43
- ANIX $2.07
- 52 Week High
- VELO $29.25
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- VELO N/A
- ANIX 45.33
- Support Level
- VELO N/A
- ANIX $2.93
- Resistance Level
- VELO N/A
- ANIX $3.20
- Average True Range (ATR)
- VELO 0.00
- ANIX 0.11
- MACD
- VELO 0.00
- ANIX 0.01
- Stochastic Oscillator
- VELO 0.00
- ANIX 17.86
About VELO Velo3D Inc. Common stock
Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.